» Articles » PMID: 25066125

Zinc Binding Directly Regulates Tau Toxicity Independent of Tau Hyperphosphorylation

Overview
Journal Cell Rep
Publisher Cell Press
Date 2014 Jul 29
PMID 25066125
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Tau hyperphosphorylation is thought to underlie tauopathy. Working in a Drosophila tauopathy model expressing a human Tau mutant (hTauR406W, or Tau(∗)), we show that zinc contributes to the development of Tau toxicity through two independent actions: by increasing Tau phosphorylation and, more significantly, by directly binding to Tau. Elimination of zinc binding through amino acid substitution of Cys residues has a minimal effect on phosphorylation levels yet essentially eliminates Tau toxicity. The toxicity of the zinc-binding-deficient mutant Tau(∗) (Tau(∗)C2A) and overexpression of native Drosophila Tau, also lacking the corresponding zinc-binding Cys residues, are largely impervious to zinc concentration. Importantly, restoration of zinc-binding ability to Tau(∗) by introduction of a zinc-binding residue (His) into the original Cys positions restores zinc-responsive toxicities in proportion to zinc-binding affinities. These results indicate zinc binding is a substantial contributor to tauopathy and have implications for therapy development.

Citing Articles

Extremely Low-Frequency and Low-Intensity Electromagnetic Field Technology (ELF-EMF) Sculpts Microtubules.

Lobyntseva A, Ganaiem M, Ivashko-Pachima Y, Barnstable C, Weisinger B, Parabucki A Eur J Neurosci. 2025; 61(4):e70023.

PMID: 39966100 PMC: 11835790. DOI: 10.1111/ejn.70023.


Hyperhomocysteinemia Is Associated With a Myriad of Age-Related Illnesses: A Potential Role for Metal Toxicity.

Olsen T, Refsum H, Eiser A Mayo Clin Proc. 2024; 99(9):1362-1368.

PMID: 38935017 PMC: 11374489. DOI: 10.1016/j.mayocp.2024.04.016.


Copper(II), Nickel(II) and Zinc(II) Complexes of Peptide Fragments of Tau Protein.

Kastal Z, Balaban A, Vida S, Kallay C, Nagy L, Varnagy K Molecules. 2024; 29(10).

PMID: 38792033 PMC: 11123990. DOI: 10.3390/molecules29102171.


Development of fluorophores for the detection of oligomeric aggregates of amyloidogenic proteins found in neurodegenerative diseases.

Teppang K, Zhao Q, Yang J Front Chem. 2024; 11:1343118.

PMID: 38188930 PMC: 10766704. DOI: 10.3389/fchem.2023.1343118.


Treatment with 1, 10 Phenanthroline-5-Amine Reduced Amyloid Burden in a Mouse Model of Alzheimer's Disease.

Schmued L, Maloney B, Schmued C, Lahiri D J Alzheimers Dis. 2023; 97(1):239-247.

PMID: 38073385 PMC: 10789349. DOI: 10.3233/JAD-221285.


References
1.
Kim I, Park E, Seo J, Ko S, Lee J, Kim C . Zinc stimulates tau S214 phosphorylation by the activation of Raf/mitogen-activated protein kinase-kinase/extracellular signal-regulated kinase pathway. Neuroreport. 2011; 22(16):839-44. DOI: 10.1097/WNR.0b013e32834c0a2d. View

2.
Venter P, Dirksen A, Thomas D, Manchester M, Dawson P, Schneemann A . Multivalent display of proteins on viral nanoparticles using molecular recognition and chemical ligation strategies. Biomacromolecules. 2011; 12(6):2293-301. PMC: 3114102. DOI: 10.1021/bm200369e. View

3.
Lannfelt L, Blennow K, Zetterberg H, Batsman S, Ames D, Harrison J . Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2008; 7(9):779-86. DOI: 10.1016/S1474-4422(08)70167-4. View

4.
Bush A . The metallobiology of Alzheimer's disease. Trends Neurosci. 2003; 26(4):207-14. DOI: 10.1016/S0166-2236(03)00067-5. View

5.
Solomons N . Competitive interaction of iron and zinc in the diet: consequences for human nutrition. J Nutr. 1986; 116(6):927-35. DOI: 10.1093/jn/116.6.927. View